Fibrosis–a common pathway to organ injury and failure
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
Fibrosis is a consequence of the inflammatory response. When fibrotic tissue becomes excessive, it can have diverse pathophysiological effects on a number of organ systems. The mechanisms underlying fibrosis and approaches to therapy are reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatocyte injury, apoptosis and necrosis promote a sterile inflammatory response. This includes activation of KCs to clear necrotic debris, recruitment of lymphocytes and bone-marrow-derived monocytes, extracellular matrix (ECM) remodelling, myofibroblast activation, angiogenesis, and hepatocyte regeneration and differentiation to replace lost hepatocytes.11,31,32”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
In the citing paper
“Both receptors are independently involved in regulation of cell adhesion, differentiation, proliferation of myofibroblasts and migration of both myofibroblasts and macrophages.31”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Research works printed but not linked: 1
- TORAFIC Investigators Group, 2011, Clin Ther, 33, 1204.e3
Cited by
Items 701–800 of 1,001
Lee, H. W., Lee, D. H., Lee, J., Lee, S., Koo, B. K., Joo, S. K., Heo, E. Y., Jung, Y. J., Kim, W. K., & Kim, D. K. (2020) · Liver International · doi:10.1111/liv.14626 · Cited by 17
The regulatory role of the BDNF/TrkB pathway in organ and tissue fibrosis.
Hang, P., Ge, F.-Q., Li, P., Liu, J., Zhu, H., & Zhao, J. (2021) · PubMed · doi:10.14670/hh-18-368 · Cited by 20
Vetuschi, A., Battista, N., Pompili, S., Cappariello, A., Prete, R., Taticchi, A., Selvaggini, R., Giovanni Latella, G., Corsetti, A., & Sferra, R. (2021) · Nutrition · doi:10.1016/j.nut.2021.111511 · Cited by 15
Shamloo, K., Weng, J., Ross, C. A., Lee, J., Alfuraih, S., Totonchy, J. E., & Sharma, A. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.13.10 · Cited by 16
Ghorbaninejad, M., Meyfour, A., Maleknia, S., Shahrokh, S., Abdollahpour‐Alitappeh, M., & Asadzadeh‐Aghdaei, H. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105382 · Cited by 16
Chang, Y.-T., Chung, M., Chang, C.-H., Chiu, K.-H., Shieh, J., & Wu, M. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2088809 · Cited by 15
Bariatric surgery for diabetic comorbidities: A focus on hepatic, cardiac and renal fibrosis
Ding, H., Zhang, Y., Ma, X., Zhang, Z., Xu, Q., Liu, C., Li, B., Dong, S., Li, L., Zhu, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1016635 · Cited by 16
The effect of BMP9 on inflammation in the early stage of pulpitis
Song, T., Li, X., Liu, L. I. U., Zeng, Y., Song, D., & Huang, D. (2023) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2022-0313 · Cited by 15
Wang, J., Liu, C., Wang, T., Li, S., Bai, Y., Fulin, P., Wang, J., Han, J., Luo, R., Wan, X., et al. (2023) · Immunology Letters · doi:10.1016/j.imlet.2023.09.005 · Cited by 17
Properties and Immune Function of Cardiac Fibroblasts
Furtado, M. B., & Hasham, M. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57613-8_3 · Cited by 15
Adiponectin: A potential candidate for treating fibrosis in posterior segment of the eye
Palanisamy, K., Raman, R., Sulochana, K. N., & Chidambaram, S. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.12.005 · Cited by 16
Exploring organ-specific features of fibrogenesis using murine precision-cut tissue slices
Bigaeva, E., Gore, E., Mutsaers, H. A. M., Oosterhuis, D., Kim, Y. O., Schuppan, D., Bank, R. A., Boersema, M., & Olinga, P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165582 · Cited by 19
Basta, M. D., Petruk, S., Summer, R., Rosenbloom, J., Wermuth, P. J., Macarak, E., Levin, A. V., Mazo, A., & Walker, J. L. (2023) · iScience · doi:10.1016/j.isci.2023.106570 · Cited by 14
Setdb1 ablation in macrophages attenuates fibrosis in heart allografts
Ma, Z., Zhou, X. K., Jia, W., Tan, X., Huang, X., Wang, J., Sun, L., Li, Q., Zhao, X., Yuan, N., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2424534122 · Cited by 14
Regulation of transforming growth factor-β signalling by SUMOylation and its role in fibrosis
Wang, X., Liu, T., Huang, Y., Dai, Y., & Lin, H. (2021) · Open Biology · doi:10.1098/rsob.210043 · Cited by 17
Tackling the effects of extracellular vesicles in fibrosis
Martín-Taboada, M., Corrales, P., Medina‐Gómez, G., & Vila‐Bedmar, R. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151221 · Cited by 16
Hasselbalch, H. C., Junker, P., Skov, V., Kjær, L., Knudsen, T. A., Larsen, M. K., Holmström, M. O., Andersen, M. H., Jensen, C., Karsdal, M. A., et al. (2023) · Cancers · doi:10.3390/cancers15174323 · Cited by 16
Karaman, E., Önder, G. Ö., Göktepe, Ö., Karakaş, E., Mat, Ö. C., Bolat, D., Köseoğlu, E., Tur, K., Baran, M., Ermiş, M., et al. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03871-1 · Cited by 16
Atg5 deficiency in macrophages protects against kidney fibrosis via the CCR6-CCL20 axis
Zhu, Y., Tan, J., Wang, Y., Gong, Y., Zhang, X., Yuan, Z., Lu, X., Tang, H., Zhang, Z., Jiang, X., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01600-2 · Cited by 15
She, D., Jiang, S., & Yuan, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-61771-3 · Cited by 14
Liu, L., Wang, B., Ma, Y., Sun, K., Wang, P., Li, M., Dong, J., Qin, M., Li, M., Wei, C., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1443667 · Cited by 24
Rath, S. K., Nyamsuren, G., Tampe, B., Yu, D. S., Hulshoff, M. S., Schlösser, D., Maamari, S., Zeisberg, M., & Zeisberg, E. M. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01719-6 · Cited by 16
Rungratanawanich, W., LeFort, K. R., Cho, Y., Li, X., & Song, B. (2024) · Journal of Pineal Research · doi:10.1111/jpi.13007 · Cited by 14
Physical Exercise: A Promising Treatment Against Organ Fibrosis
Ma, X., Liu, B., Jiang, Z., Rao, Z., & Zheng, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010343 · Cited by 15
Immune Checkpoints and the Immunology of Liver Fibrosis
Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 17
Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches
Ning, Z.-H., Wang, X., Zhao, Y., Ou, Y., Yang, J., Tang, H., & Hu, H.-J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114341 · Cited by 16
Wang, Y., Jiang, H., Chen, Q., Guo, F., Zhang, B., Hu, L., Huang, X., Shen, W., Gao, J., Chen, W., et al. (2025) · Biomaterials Research · doi:10.34133/bmr.0179 · Cited by 14
Nolan, L. S., Sherman, J., Miller, M. M., Zaghouani, H., & Sherman, M. P. (2015) · Neonatology · doi:10.1159/000431305 · Cited by 14
Sferra, R., Vetuschi, A., Pompili, S., Gaudio, E., Speca, S., & Latella, G. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.11.004 · Cited by 17
Repurposing mesalazine against cardiac fibrosis in vitro
Hoffmann, M., Kant, T. A., Emig, R., Rausch, J. S. E., Newe, M., Schubert, M., Künzel, K., Winter, L., Klapproth, E., Peyronnet, R., et al. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01998-9 · Cited by 14
Gabbiadini, R., Zacharopoulou, E., Furfaro, F., Craviotto, V., Zilli, A., Gilardi, D., Roda, G., Loy, L., Fiorino, G., Peyrin‐Biroulet, L., et al. (2020) · Current Drug Targets · doi:10.2174/1389450121666201119142919 · Cited by 17
Gao, Q., Zhang, H., Chen, Z.-T., Li, Y., Wang, S., Wen, Z., Xie, Y., Mai, J., Wang, J., & Chen, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.503256 · Cited by 17
Zhang, L., Wang, X., He, S., Zhang, F., & Li, Y. X. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116466 · Cited by 17
Kotsiri, I., Hadziyannis, E. S., Georgiou, A. N., Papageorgiou, M., Vlachogiannakos, J., & Papatheodoridis, G. (2016) · PubMed Central · Cited by 21
The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis
Meiners, S., Evankovich, J. W., & Mallampalli, R. K. (2018) · Translational research · doi:10.1016/j.trsl.2018.03.003 · Cited by 16
Yu, R., Li, Z., Liu, S., Huwatibieke, B., Li, Y., Yin, Y., & Zhang, W. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.027 · Cited by 14
Pathogenesis investigation of miR‐199‐5p in oral submucous fibrosis based on bioinformatics analysis
Yuan, Y., Li, N., Zeng, L., Shen, Z., & Jiang, C. (2018) · Oral Diseases · doi:10.1111/odi.13008 · Cited by 14
Stem-cell regenerative medicine as applied to the penis
Pozzi, E., Muneer, A., Sangster, P., Alnajjar, H. M., Salonia, A., Bettocchi, C., Castiglione, F., & Ralph, D. J. (2019) · Current Opinion in Urology · doi:10.1097/mou.0000000000000636 · Cited by 16
The long noncoding RNA Ptprd-IR is a novel molecular target for TGF-β1-mediated nephritis
Pu, Y., Zhao, H., Wu, X., Mei, M., & Shen, B. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105742 · Cited by 14
Impact of Heparanse on Organ Fibrosis
Masola, V., Gambaro, G., & Onisto, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34521-1_27 · Cited by 14
Role of Fibroblast‐Immune Crosstalk in Kidney, Lung, and Skin Tertiary Lymphoid Structures
Cross, A. R., Shelley, J. R., Newman, R., Strid, J., & Denton, A. E. (2025) · Immunological Reviews · doi:10.1111/imr.70059 · Cited by 15
Zhu, B., Liu, Y., Qi, D., Zhao, L., Yang, X., Su, E., Zhu, Z., Zhang, Y., & Gao, C. (2021) · Kidney & Blood Pressure Research · doi:10.1159/000521100 · Cited by 14
Zhong, X. Y., Song, Z., Ning, Z., Wu, J., & Song, X. (2022) · Microvascular Research · doi:10.1016/j.mvr.2022.104347 · Cited by 15
Knockdown of Yap attenuates TAA-induced hepatic fibrosis by interaction with hedgehog signals
Zhao, Y., Wang, H., He, T., Ma, B., Chen, G., & Tzeng, C. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00775-6 · Cited by 14
Novel bioprinted 3D model to human fibrosis investigation
Petrachi, T., Portone, A., Arnaud, G., Ganzerli, F., Bergamini, V., Resca, E., Accorsi, L., Ferrari, A., Delnevo, A., Rovati, L. L., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115146 · Cited by 13
Dental Pulp Stem Cells Modulate Inflammasome Pathway and Collagen Deposition of Dermal Fibroblasts
Zanini, G., Bertani, G., Tinco, R. D., Pisciotta, A., Bertoni, L., Selleri, V., Generali, L., Marconi, A., Mattioli, A. V., Pinti, M., et al. (2024) · Cells · doi:10.3390/cells13100836 · Cited by 14
Trained immunity suppression determines kidney allograft survival
Jonkman, I., Jacobs, M. M. E., Negishi, Y., Yanginlar, C., Martens, J. H. A., Baltissen, M. P. A., Vermeulen, M., van den Hoogen, M. W. F., Baas, M. C., van der Vlag, J., et al. (2024) · American Journal of Transplantation · doi:10.1016/j.ajt.2024.08.006 · Cited by 16
Different impact of chronic kidney disease in older patients with heart failure according to frailty
Díez‐Villanueva, P., Jiménez-Méndez, C., Pérez-Rivera, J.-Á., Barge‐Caballero, E., López, J., Ortiz, C., Bonanad, C., Artaza, J. G., Esteban‐Fernández, A., Cobo, M., et al. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.12.001 · Cited by 14
Xiao, Z., Wang, Y., Chen, Y., Jin, L., Shi, Y., Liu, C., Fu, C., & Cao, Y. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00219.2024 · Cited by 13
Preventing the progression of cirrhosis to decompensation and death
Villanueva, C., Tripathi, D., & Bosch, J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-01031-x · Cited by 40
Bjurling, J., Chavkin, N. W., Halvardson, J., Thel, M. C., Mattisson, J., Kim, J. S., Zaghlool, A., Ma, S., Martínez, F. J., Anstrom, K. J., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00966-9 · Cited by 17
Aschner, Y., Nelson, M., Brenner, M., Roybal, H. M., Beke, K. M., Meador, C., Foster, D. G., Correll, K. A., Reynolds, P. R., Anderson, K. C., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00235.2019 · Cited by 15
Xue, Y., Qian, K., Sun, Y.-C., Xiao, L., & Shi, X. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10395 · Cited by 16
Proximal tubule cyclophilin D mediates kidney fibrogenesis in obstructive nephropathy
Jang, H., Noh, M. R., Ha, L., Kim, J., & Padanilam, B. J. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00171.2021 · Cited by 15
Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn’s Disease
Ueno, A., Jijon, H. B., Peng, R., Sparksman, S., Mainoli, B., Filyk, A., Li, Y., Wilson, S. R., Novak, K. L., Panaccione, R., et al. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab157 · Cited by 14
Hur, M., Park, M., Moon, H., Choe, W. H., & Lee, C. H. (2021) · Annals of Laboratory Medicine · doi:10.3343/alm.2022.42.2.249 · Cited by 14
Role of melatonin in respiratory diseases (Review)
Li, L., Gang, X., Wang, J., & Gong, X. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11197 · Cited by 15
Koenen, M. T., Brandt, E. F., Kaczor, D., Caspers, T., Heinzmann, A. C. A., Fischer, P., Heinrichs, D., Wirtz, T. H., Trautwein, C., Koenen, R. R., et al. (2022) · Biomolecules · doi:10.3390/biom12050698 · Cited by 15
Effect of Pheretima aspergillum on reducing fibrosis: A systematic review and meta-analysis
Xu, T., Liu, X., Wang, S., Kong, H., Yu, X., Liu, C., Song, H., Gao, P., & Zhang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1039553 · Cited by 13
The Application of Berberine in Fibrosis and the Related Diseases
Gao, R., Lu, Y., Zhang, W., & Zhang, Z. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500307 · Cited by 13
Park, J., Lee, H., Kim, S. K., Yi, J., Shin, D. G., Lee, J., Kim, Y., Kim, Y. J., & Joung, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-34145-9 · Cited by 17
Wang, Y., Michiels, T., Setroikromo, R., van Merkerk, R., Cool, R. H., & Quax, W. J. (2019) · FEBS Journal · doi:10.1111/febs.14925 · Cited by 15
Unravelling fibrosis using single-cell transcriptomics
Dobie, R., & Henderson, N. C. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.09.004 · Cited by 14
Hasselbalch, H. C., Skov, V., Kjær, L., Sørensen, T. L., Ellervik, C., & Wienecke, T. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01877-3 · Cited by 13
Blueberry Juice Attenuates Pulmonary Fibrosis via Blocking the TGF-β1/Smad Signaling Pathway
Li, Y., Wang, L., Zhang, Q., Li, T., Gan, C., Liu, H., Yin, W., & Ye, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.825915 · Cited by 20
Wang, Z., Wang, Y., Luo, F., Zhai, Y., Li, J., Chen, Y., Li, Q., Zhu, L., Jiao, S., Liu, P., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.960259 · Cited by 15
Progress in molecular mechanisms of coronary microvascular dysfunction
Li, H., Gao, Y., & Lin, Y. (2023) · Microcirculation · doi:10.1111/micc.12827 · Cited by 13
Wang, Q., Tang, X., Wang, Y., Zhang, D.-Y., Li, X., & Liu, S. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.009 · Cited by 13
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis
Chen, S., Zhuang, D., Jia, Q., Guo, B., & Hu, G. (2024) · Biomaterials Research · doi:10.34133/bmr.0042 · Cited by 18
Metabolism and bioenergetics in the pathophysiology of organ fibrosis
Miguel, V., Alcalde‐Estévez, E., Sirera, B., Rodríguez‐Pascual, F., & Lamas, S. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.001 · Cited by 13
Suffredini, G., Gao, W. D., & Dodd‐o, J. M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133633 · Cited by 19
Milara, J., Ribera, P., Marín, S., Montero, P., Roger, I., & Cortijo, J. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00906-8 · Cited by 13
Chang, X. Y., Han, Y., Li, Q., Wang, C., Guo, B., & Jiang, H. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.061 · Cited by 12
Sherif, M. M., Abdelaziz, N. A., Alshahrani, M. Y., Saleh, S. E., & Aboshanab, K. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-99788-x · Cited by 12
Role of cGAS-STING pathway in fibrotic disease
Feng, L., Zhang, F., Cao, J., & Xiong, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107971 · Cited by 15
Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl4-Induced Liver Fibrosis
Yan, Y., Guan, C., Du, S., Zhu, W., Ji, Y., Su, N., Mei, X., He, D., Lu, Y., Zhang, C., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00514 · Cited by 13
Laser fluorescence spectroscopy and optical tissue oximetry in the diagnosis of skin fibrosis
Chursinova, Y. V., Куликов, Д. А., Рогаткин, Д. А., Raznitsyna, I. A., Mosalskaya, D. V., Bobrov, M. A., Николаевна, П. Е., & Molochkov, A. V. (2019) · Biomedical Photonics · doi:10.24931/2413-9432-2019-8-1-38-45 · Cited by 12
Biomarkers of Chronic Renal Tubulointerstitial Injury
Bagnasco, S. M., & Rosenberg, A. Z. (2019) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155419861092 · Cited by 12
Ferreira, D. S., Arora, G., Gieseck, R. L., Rotile, N. J., Waghorn, P. A., Tanabe, K. K., Wynn, T. A., Caravan, P. D., & Fuchs, B. C. (2020) · Investigative Radiology · doi:10.1097/rli.0000000000000737 · Cited by 13
Glutamine Inhibition Reduces Iatrogenic Laryngotracheal Stenosis
Tsai, H., Lina, I. A., Motz, K., Chung, L., Ding, D., Murphy, M. K., Feeley, M., Elisseeff, J. H., & Hillel, A. T. (2021) · The Laryngoscope · doi:10.1002/lary.29385 · Cited by 12
Angiotensin‐converting enzyme inhibitor prevents skeletal muscle fibrosis in diabetic mice
Kakutani, N., Takada, S., Nambu, H., Maekawa, S., Hagiwara, H., Yamanashi, K., Obata, Y., Nakano, I., Fumoto, Y., Hata, S., et al. (2021) · Experimental Physiology · doi:10.1113/ep089375 · Cited by 12
Sansilvestri, P., Crochemore, N. H., Bertin, F., Bertheux, H., de Conchard, G. V., Diguet, N., Desfosses, E., Lecomte, M., González, A., Díez, J., et al. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001122 · Cited by 12
Zebrafish Model to Study Angiotensin II-Mediated Pathophysiology
Joshi, B., Wagh, G., Kaur, H., & Patra, C. (2021) · Biology · doi:10.3390/biology10111177 · Cited by 13
Fang, Q., Liu, S., Cui, J., Zhao, R., Han, Q., Hou, P., Li, Y., Lv, J., Zhang, X., Luo, Q., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.920766 · Cited by 15
Inoue, T., Nakamura, Y., Tanaka, S., Kohro, T., Li, L. X., Huang, L., Yao, J., Kawamura, S., Inoue, R., Nishi, H., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.993698 · Cited by 13
Choi, J.-H., Cho, Y. S., Choi, H., Lee, S., Han, H.-J., Lee, J., & Kwon, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043439 · Cited by 15
Serum biomarkers for liver fibrosis assessment
Maroto‐García, J., Álvarez, A. M., de Pedro, M. P. S., Soto, A. B., & González, Á. (2023) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2023-0081 · Cited by 25
Perspectives on Post-COVID-19 Pulmonary Fibrosis Treatment
Cojocaru, E., Cojocaru, T., Pînzariu, G.-M., Vasiliu, I., Armașu, I., & Cojocaru, C. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm14010051 · Cited by 15
The advancements of heparanase in fibrosis.
Lv, Q., Zeng, J., & He, L. (2016) · PubMed Central · Cited by 12
Sinomenine's protective role and mechanism in stress load-induced heart failure
Fu, Y.-F., Li, L., Fang, P., Song, J., Sun, X., Meng, T.-H., & Tao, H. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13181 · Cited by 12
Reversal of lung fibrosis: an unexpected finding in survivor of acute respiratory distress syndrome
Chang, C.-H., Juan, Y. H., Hu, H., Kao, K. C., & Lee, C.-S. (2017) · QJM · doi:10.1093/qjmed/hcx190 · Cited by 12
Potential link between microRNA-208 and cardiovascular diseases
Zhang, X., & Xu, M. (2021) · Journal of Xiangya Medicine · doi:10.21037/jxym-21-8 · Cited by 12
Can Tissue Stiffness Measured Using Shear-Wave Elastography Represent Lymphedema in Breast Cancer?
Lee, D. G., & Cho, J. H. (2022) · Lymphatic Research and Biology · doi:10.1089/lrb.2021.0099 · Cited by 12
Zhou, M.-S., Zheng, S.-Y., Chen, C., Li, X., Zhang, Q., Zhao, Y., & Zhang, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115975 · Cited by 11
O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblasts
Very, N., Boulet, C., Gheeraert, C., Berthier, A., Johanns, M., Saleh, M. B., Guille, L., Bray, F., Strub, J., Bobowski, M., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06773-9 · Cited by 15
The roles of orphan nuclear receptor 4 group A1 and A2 in fibrosis
Gao, L., Wang, H., Fang, F., Liu, J., Zhao, C., Niu, J., Wang, Z., Zhong, Y., & Wang, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112705 · Cited by 12
Targeting SIRT2 in Aging-Associated Fibrosis Pathophysiology
Huang, Y., He, W. G., Zhang, Y., Zou, Z., Han, L., Luo, J., Wang, Y., Tang, X., Li, Y., Bao, Y., et al. (2024) · Aging and Disease · doi:10.14336/ad.202.0513 · Cited by 12
Jia, Y., Wei, Z., Feng, J., Lei, M., Yang, Y., Liu, J., Ma, Y., Chen, W., Huang, G., Genin, G. M., et al. (2024) · Research · doi:10.34133/research.0517 · Cited by 17
Ge, M., Zou, H., Chen, J., Zhang, Q.-Y., Li, C., Yang, J., Wu, J., Xie, X., Liu, J., Lei, L., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.10.022 · Cited by 13
Regulated cell death in chronic kidney disease: current evidence and future clinical perspectives
Giuliani, K. T. K., Adams, B. C., Healy, H. G., & Kassianos, A. J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1497460 · Cited by 11
Metadata
- Authors
- Rockey, D. C., Bell, P. D., & Hill, J. A.
- Affiliations
- Medical University of South Carolina (US)
- The University of Texas Southwestern Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-19
- Volume
- 372
- Issue
- 12
- Pages
- 1138-1149
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1977437151
- Cited by
- 1,428
- References
- 118
- Citations by year
- 2026: 104 · 2025: 116 · 2024: 154 · 2023: 149 · 2022: 162 · 2021: 162 · 2020: 152 · 2019: 118 · 2018: 96 · 2017: 94 · 2016: 85 · 2015: 33
- FWCI
- 14.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- fibrosis, organ damage, organ failure, inflammation, fibrosis mechanisms, fibrosis treatment
- MeSH terms
- Fibrosis, Humans, Multiple Organ Failure, Transforming Growth Factor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.